ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2818

Associations of IL23R, BMP6 and PTGS1 Polymorphisms with Radiographic Severity of Ankylosing Spondylitis

Gulsen Ozen1, Rabia Deniz2, Fatih Eren3, Can Erzik3, Ali Ugur Unal1, Sibel Z. Aydin4, Nevsun Inanc1, Haner Direskeneli1 and Pamir Atagunduz1, 1Department of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey, 2Marmara University Faculty of Medicine, Istanbul, Turkey, 3Department of Medical Biology, Marmara University Faculty of Medicine, Istanbul, Turkey, 4Department of Rheumatology, Koc University Faculty of Medicine, Istanbul, Turkey

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Ankylosing spondylitis (AS), genetics, radiography and severity

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Spondylarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Ankylosing spondylitis (AS) is an inflammatory disease affecting spine which may lead to new bone formation and disability. However, the radiographic severity of AS shows great variance. The genetic determinants for the new bone formation and for this great variance have not been fully understood yet. By using a well-categorized group of patients representing two extreme ends of AS radiographic severity, we aimed to determine the effects of interleukin-23 receptor (IL23R), bone morpogenetic protein-6 (BMP6) and prostaglandin endoperoxide synthase-1 (PTGS1) gene variants on radiographic severity of AS.

Methods: rs11209026 (IL23R), rs1235192 and rs270378 (BMP6), and rs1236913 (PTGS1) single nucleotide polymorphisms (SNPs) were genotyped in 241 AS patients (F/M=97/144, mean age 42.0±11.0 years, 60.6% HLA-B27[+]) fulfilling the modified New York criteria.  Patients were classifed as mild and severe radiographic AS according to modified Stoke AS spinal score (mSASSS). Mild AS is defined as having mSASSS of “0” despite ≥10 years of disease duration. Whereas severe AS is defined as having mSASSS of >20 (without counting scores with “1”) regardless of the disease duration.

Results: Seventy (29%) and 171 (71%) patients were classified as severe and mild radiographic AS, respectively (mean mSASSS 48.2±17.3 vs 0, P<0.0001).  Severe AS patients were mainly male and significantly older, had longer disease duration, more extra-articular and coxofemoral joint involvement, smoking rates, HLA-B27 positivity and ever TNFi usage. The genotype distributions and allele frequencies of the 4 SNPs were not different in severe group compared to mild group. After adjustment for clinical differences between two groups by logistic regression analysis none of the alleles in those SNPs were found to be associated with radiographic severity of the AS (Table 1). The genotype frequencies also did not change when groups were categorized according to gender and HLA-B27 status. However, HLA-B27 was associated with radiographic severity only in male patients (OR=3.23, 95% CI [1.11 to 9.41], P=0.032). No association with these SNPs and other clinical manifestations of AS, coxofemoral joint involvement, uveitis and enthesitis, could be demonstrated. Severe group patients had higher CRP levels, likewise patients with elevated CRP had higher mSASSS scores (22.1±26.9 vs 10.4±22.4, P=0.001). However no difference was identified.in genotype distributions and allele frequencies of patients with and without elevated CRP.

Conclusion: In a radiographically well-categorized AS cohort IL23R rs11209026, BMP6 rs1235192 and rs270378 and PTGS1rs1236913 SNPs are not found to be associated with radiographic severity of AS. HLA-B27 is associated with radiographic severity only in male AS patients.

Table 1. The distribution of allele frequencies of IL23R, BMP6 and PTGS1 SNPs of mild and severe radiographic AS patients*

 

Mild radiographic AS (n=171)

Severe radiographic AS (n=70)

P value

OR (95% CI)

 

Allele frequency

IL23R rs11209026

G

Aǂ

 

156 (91.2)

15 (8.8)

 

66 (94.3)

4 (5.7)

0.42

0.28 (0.058 to 1.36)

BMP6 rs1235192

A

Cǂ

 

100 (58.5)

71 (41.5)

 

39 (55.7)

31 (44.3)

0.69

1.14 (0.53 to 2.48)

BMP6 rs270378

T

Cǂ

 

23 (13.5)

148 (86.5)

 

10 (14.3)

60 (85.7)

0.86

0.92 (0.30 to 2.75)

PTGS1 rs1236913

C

Tǂ

 

145 (84.8)

26 (15.2)

 

59 (84.3)

11 (15.7)

0.92

1.10 (0.39 to 3.08)

*Values are provided as n (%). ǂ Risky allele


Disclosure: G. Ozen, None; R. Deniz, None; F. Eren, None; C. Erzik, None; A. U. Unal, None; S. Z. Aydin, None; N. Inanc, None; H. Direskeneli, None; P. Atagunduz, None.

To cite this abstract in AMA style:

Ozen G, Deniz R, Eren F, Erzik C, Unal AU, Aydin SZ, Inanc N, Direskeneli H, Atagunduz P. Associations of IL23R, BMP6 and PTGS1 Polymorphisms with Radiographic Severity of Ankylosing Spondylitis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/associations-of-il23r-bmp6-and-ptgs1-polymorphisms-with-radiographic-severity-of-ankylosing-spondylitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/associations-of-il23r-bmp6-and-ptgs1-polymorphisms-with-radiographic-severity-of-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology